BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1898593)

  • 1. Reversible effects of sodium butyrate on the differentiation of F9 embryonal carcinoma cells.
    Kosaka M; Nishina Y; Takeda M; Matsumoto K; Nishimune Y
    Exp Cell Res; 1991 Jan; 192(1):46-51. PubMed ID: 1898593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
    Levine RA; Campisi J; Wang SY; Gudas LJ
    Dev Biol; 1984 Oct; 105(2):443-50. PubMed ID: 6090244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hinokitiol induces differentiation of teratocarcinoma F9 cells.
    Muto N; Dota A; Tanaka T; Itoh N; Okabe M; Inada A; Nakanishi T; Tanaka K
    Biol Pharm Bull; 1995 Nov; 18(11):1576-9. PubMed ID: 8593483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.
    Dony C; Kessel M; Gruss P
    Nature; 1985 Oct 17-23; 317(6038):636-9. PubMed ID: 2414665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion.
    Bjersing JL; Brorsson A; Heby O
    J Cell Biochem; 1997 Dec; 67(3):378-85. PubMed ID: 9361192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium butyrate induces histone hyperacetylation and differentiation of murine embryonal carcinoma cells.
    McCue PA; Gubler ML; Sherman MI; Cohen BN
    J Cell Biol; 1984 Feb; 98(2):602-8. PubMed ID: 6141173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium butyrate inhibits c-myc and stimulates c-fos expression in all the steps of the cell-cycle in hepatoma tissue cultured cells.
    Tichonicky L; Kruh J; Defer N
    Biol Cell; 1990; 69(1):65-7. PubMed ID: 2261575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of teratocarcinoma F9 cell differentiation with cis-diammine dichloroplatinum(II) (CDDP).
    Doi T; Sumi T; Nishina Y; Kosaka M; Iwai SA; Sakuda M; Nishimune Y
    Cancer Lett; 1995 Jan; 88(1):81-6. PubMed ID: 7850777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction of jun genes during the reversible changes induced with sodium butyrate on the differentiation of F9 cells.
    Nishina Y; Sumi T; Iwai SA; Kosaka M; Nishimune Y
    Exp Cell Res; 1993 Oct; 208(2):492-7. PubMed ID: 8375477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of induction of Hox1.6 and C-jun mRNA during three different ways of inducing differentiation in teratocarcinoma F9 cells.
    Iwai SA; Nishina Y; Kosaka M; Sumi T; Doi T; Sakuda M; Nishimune Y
    In Vitro Cell Dev Biol Anim; 1995 Jun; 31(6):462-6. PubMed ID: 8589890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2.
    Souleimani A; Asselin C
    FEBS Lett; 1993 Jul; 326(1-3):45-50. PubMed ID: 8325387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
    Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
    Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of glioblastoma cell differentiation.
    Engelhard HH; Duncan HA; Dal Canto M
    Neurosurgery; 1997 Oct; 41(4):886-96; discussion 896-7. PubMed ID: 9316051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in cell-surface N-acetylglucosaminide beta (1----4)galactosyltransferase activity with retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
    Nakhasi HL; Nagarajan L; Anderson WB
    FEBS Lett; 1984 Mar; 168(2):222-6. PubMed ID: 6427003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells.
    Tanaka T; Satoh T; Onozawa Y; Kohroki J; Itoh N; Ishidate M; Muto N; Tanaka K
    Cell Biol Int; 1999; 23(8):541-50. PubMed ID: 10704238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Hox1.6, c-jun, and Oct-3 gene expressions are associated with teratocarcinoma F9 cell differentiation in three different ways of induction.
    Iwai SA; Kosaka M; Nishina Y; Sumi T; Sakuda M; Nishimune Y
    Exp Cell Res; 1993 Mar; 205(1):39-43. PubMed ID: 8453995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permissive effect of cyclic AMP and cycloheximide for induction by sodium butyrate of the glycoprotein hormone alpha-subunit gene in choriocarcinoma cells.
    Campain JA; Eudy JD; Cox GS
    Cell Growth Differ; 1994 Aug; 5(8):827-38. PubMed ID: 7527246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823.
    Shi SL; Wang YY; Liang Y; Li QF
    World J Gastroenterol; 2006 Mar; 12(11):1694-8. PubMed ID: 16586536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratocarcinoma F9 cells induced to differentiate with sodium butyrate produce both tissue-type and urokinase-type plasminogen activators.
    Takeda M; Kosaka M; Nishina Y; Sawada K; Matsumoto K; Nishimune Y
    J Cell Biochem; 1992 Jul; 49(3):284-9. PubMed ID: 1644865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol esters.
    Khuri FR; Cho Y; Talmage DA
    Cell Growth Differ; 1996 May; 7(5):595-602. PubMed ID: 8732669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.